Molecular Psychiatry

Article	Citations
Neurophysiological correlates of ketamine-induced dissociative state in bipolar disorder: insights from real-world clinical settings	1777
Risk of suicide and all-cause death in patients with mental disorders: a nationwide cohort study	957
The case for hemispheric lateralization of the human amygdala in fear processing	444
Suspected autoimmune-mediated dissociative symptoms	343
Perifornical area Urocortin-3 neuronal activation levels in response to foreign pups depends on physiological context	293
Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications	265
Bidirectional emotional regulation through prefrontal innervation of the locus coeruleus	217
Exploring the genetic heterogeneity in major depression across diagnostic criteria	212
Barriers and solutions to the adoption of translational tools for computational psychiatry	207
Hippocampal acetylcholine modulates stress-related behaviors independent of specific cholinergic inputs	204
Brain mapping across 16 autism mouse models reveals a spectrum of functional connectivity subtypes	198
Neuronal network activity and connectivity are impaired in a conditional knockout mouse model with PCDH19 mosaic expression	192
Autoantibodies against NMDA receptor 1 modify rather than cause encephalitis	185
Prefrontal, parietal, and limbic condition-dependent differences in bipolar disorder: a large-scale meta-analysis of functional neuroimaging studies	173
Neuroglia in cognitive reserve	170
βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia	168
Adolescent substance use initiation and long-term neurobiological outcomes: insights, challenges and opportunities	163
Targeted therapy of cognitive deficits in fragile X syndrome	148
Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities	136
Alternative splicing in mouse brains affected by psychological stress is enriched in the signaling, neural transmission and blood-brain barrier pathways	135
Widespread choroid plexus contamination in sampling and profiling of brain tissue	130
FXR1 regulation of parvalbumin interneurons in the prefrontal cortex is critical for schizophrenia-like behaviors	128
Reduced hippocampal gray matter volume is a common feature of patients with major depression, bipolar disorder, and schizophrenia spectrum disorders	125
Microglia shape AgRP neuron postnatal development via regulating perineuronal net plasticity	117
Abatacept inhibits Th17 differentiation and mitigates α-synuclein-induced dopaminergic dysfunction in mice	116

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential	115
Using twin-pairs to assess potential bias in polygenic prediction of externalising behaviours across development	114
Phenotypic rescue via mTOR inhibition in neuron-specific Pten knockout mice reveals AKT and mTORC1-site specific changes	112
Resting-state fMRI reveals altered functional connectivity associated with resilience and susceptibility to chronic social defeat stress in mouse brain	110
Both GEF domains of the autism and developmental epileptic encephalopathy-associated Trio protein are required for proper tangential migration of GABAergic interneurons	106
Infections and neuropsychiatric disorders: new studies document pathways to prevention and treatment	106
Schizophrenia is associated with altered DNA methylation variance	106
How does oxytocin modulate human behavior?	102
A burden of rare copy number variants in obsessive-compulsive disorder	102
Heparin treatment is associated with a delayed diagnosis of Alzheimer’s dementia in electronic health records from two large United States health systems	102
Unconsidered issues of measurement noninvariance in biological psychiatry: A focus on biological phenotypes of psychopathology	99
An IGFBP2-derived peptide promotes neuroplasticity and rescues deficits in a mouse model of Phelan-McDermid syndrome	93
Cross-sectional and longitudinal neuroanatomical profiles of distinct clinical (adaptive) outcomes in autism	92
Molecular phenotypes associated with antipsychotic drugs in the human caudate nucleus	89
Molecular genetics of cocaine use disorders in humans	89
Ucp2-dependent microglia-neuronal coupling controls ventral hippocampal circuit function and anxiety-like behavior	88
Cross-phenotype relationship between opioid use disorder and suicide attempts: new evidence from polygenic association and Mendelian randomization analyses	87
Brain-wide perception of the emotional valence of light is regulated by distinct hypothalamic neurons	86
Dynorphin / kappa-opioid receptor regulation of excitation-inhibition balance toggles afferent control of prefrontal cortical circuits in a pathway-specific manner	85
Crif1 deficiency in dopamine neurons triggers early-onset parkinsonism	84
APOE4-mediated Alzheimer disease and “Vascular”—“Meningeal Lymphatic” components: towards a novel therapeutic era?	84
Correction to: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial	82
Key role of Rho GTPases in motor disorders associated with neurodevelopmental pathologies	82
Integrating genome-wide information and wearable device data to explore the link of anxiety and antidepressants with pulse rate variability	81
Maternal COVID-19 infection associated with offspring neurodevelopmental disorders	81
Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease	80
Cortical profiles of numerous psychiatric disorders and normal development share a common pattern	80
The benefit of diagnostic whole genome sequencing in schizophrenia and other psychotic disorders	79
Adolescent social isolation decreases colonic goblet cells and impairs spatial cognition through the reduction of cystine	79
Divergent time-varying connectivity of thalamic sub-regions characterizes clinical phenotypes and cognitive status in multiple sclerosis	79
The pathogenic APP N-terminal Val225Ala mutation alters tau protein liquid-liquid phase separation and exacerbates synaptic damage	79
Child abuse associates with increased recruitment of perineuronal nets in the ventromedial prefrontal cortex: a possible implication of oligodendrocyte progenitor cells	78
Microbial infection promotes amyloid pathology in a mouse model of Alzheimer’s disease via modulating γ-secretase	77
Human ARHGEF9 intellectual disability syndrome is phenocopied by a mutation that disrupts collybistin binding to the GABAA receptor α2 subunit	77
Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine	77
Newly identified structures of trace-amine associated receptor-1 (TAAR1) will aid discovery of next generation neuropsychiatric drugs	77
In vivo study sheds new light on the dendritic spine pathology hypothesis of schizophrenia	76
The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis	76
Assessment of early neurocognitive functioning increases the accuracy of predicting chronic PTSD risk	75
Human iN neuronal model of schizophrenia displays dysregulation of chromogranin B and related neuropeptide transmitter signatures	74
In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach	73
HuM195 and its single-chain variable fragment increase Aβ phagocytosis in microglia via elimination of CD33 inhibitory signaling	73
Abnormal dynamic functional connectivity during fear extinction learning in PTSD and anxiety disorders	72
Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT	71
Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study	71
Genetics of environmental sensitivity and its association with variations in emotional problems, autistic traits, and wellbeing	71
Time will tell. Reply to “Comments to pharmacological and behavioral divergence of ketamine enantiomers by Jordi Bonaventura et al.” by Chen et al.	71
Electric field distribution models in ECT research	71
Gestational epigenetic age and ADHD symptoms in childhood: a prospective, multi-cohort study	70
Loss of mGlu5 receptors in somatostatin-expressing neurons alters negative emotional states	68

Ca2+-permeable AMPA receptors set the threshold for retrieval of drug memories	68
The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity, and memory deficits in Down syndrome	68
Central amygdala corticotropin-releasing factor neurons promote hyponeophagia but do not control alcohol drinking in mice	68
Structural deviations of the posterior fossa and the cerebellum and their cognitive links in a neurodevelopmental deletion syndrome	67
Integrative analysis of genetics, epigenetics and RNA expression data reveal three susceptibility loci for smoking behavior in Chinese Han population	67
Genome-wide association study of traumatic brain injury in U.S. military veterans enrolled in the VA million veteran program	66
Correction to: The essence of autism: fact or artefact?	66
Sex differences in methylphenidate-induced dopamine increases in ventral striatum	66
Neurocognition and NMDAR co-agonists pathways in individuals with treatment resistant first-episode psychosis: a 3-year follow-up longitudinal study	66
Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia	66
Mitochondrial health index correlates with plasma circulating cell-free mitochondrial DNA in bipolar disorder	65
Cortical morphology in patients with the deficit and non-deficit syndrome of schizophrenia: a worldwide meta- and mega-analyses	65
Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission	65
Effects of deep brain stimulation on cognitive functioning in treatment-resistant depression: a systematic review and meta-analysis	63
Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders	63
Nurture outpaces nature: fostering with an attentive mother alters social dominance in a mouse model of stress sensitivity	63
Prion-like properties of the mutant huntingtin protein in living organisms: the evidence and the relevance	63
Deficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice	62
The effects of methylphenidate and atomoxetine on Drosophila brain at single-cell resolution and potential drug repurposing for ADHD treatment	62
EF1α-associated protein complexes affect dendritic spine plasticity by regulating microglial phagocytosis in Fmr1 knock-out mice	62
Astrocytes in the adult dentate gyrus—balance between adult and developmental tasks	62
From multivariate methods to an AI ecosystem	60
The role of PPAR-γ in memory deficits induced by prenatal and lactation alcohol exposure in mice	60
Age-related vulnerability of the human brain connectome	60
Psychedelics and ketamine are a symptom of psychiatry’s woes, not a cure	60
Correction: Adnp-mutant mice with cognitive inflexibility, CaMKIIα hyperactivity, and synaptic plasticity deficits	59
Changes in cerebral connectivity and brain tissue pulsations with the antidepressant response to an equimolar mixture of oxygen and nitrous oxide: an MRI and ultrasound study	58
Correction: Adeno-associated virus (AAV) 9-mediated gene delivery of Nurr1 and Foxa2 ameliorates symptoms and pathologies of Alzheimer disease model mice by suppressing neuro-inflammation and glial pa	58
Activation of cell-free mtDNA-TLR9 signaling mediates chronic stress-induced social behavior deficits	58
Diversity of mechanism of action of psychotropic drugs in their anti-COVID-19 properties	58
Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation	57
The acute phase protein lactoferrin is a key feature of Alzheimer’s disease and predictor of Aβ burden through induction of APP amyloidogenic processing	57
PPARα and PPARγ are expressed in midbrain dopamine neurons and modulate dopamine- and cannabinoid-mediated behavior in mice	57
Circadian rhythm disruptions associated with opioid use disorder in synaptic proteomes of human dorsolateral prefrontal cortex and nucleus accumbens	57
Resting-state functional connectivity changes in older adults with sleep disturbance and the role of amyloid burden	57
A new suspect in the unsolved case of neuroinflammation in schizophrenia	56
Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood–brain barrier	55
Novel epigenetic molecular therapies for imprinting disorders	55
Ethanol inhibits dopamine uptake via organic cation transporter 3: Implications for ethanol and cocaine co-abuse	55
Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders	55
Dynamic and progressive changes in thalamic functional connectivity over the first five years of psychosis	55
Cerebrospinal fluid flow cytometry distinguishes psychosis spectrum disorders from differential diagnoses	55
An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function	54
Large-scale plasma proteomics uncovers novel targets linking ambient air pollution and depression	53
Diffusion imaging genomics provides novel insight into early mechanisms of cerebral small vessel disease	53
Life-course neighbourhood deprivation and brain structure in older adults: the Lothian Birth Cohort 1936	53
Maternal autoantibody profiles as biomarkers for ASD and ASD with co-occurring intellectual disability	52
Aberrant impulse control circuitry in obesity	52
Genetic analyses point to alterations in immune-related pathways underpinning the association between psychiatric disorders and COVID-19	52
What next for eating disorder genetics? Replacing myths with facts to sharpen our understanding	52
Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson’s disease	52
Expanding the heuristic neurocircuit-based taxonomy to guide treatment for OCD: reply to the commentary “Probing the genetic and molecular correlates of connectome alterations in obsessive-compulsive	51
Sex differences in trajectories of cortical development in autistic children from 2–13 years of age	51
Correction: A recurrent SHANK1 mutation implicated in autism spectrum disorder causes autistic-like core behaviors in mice via downregulation of mGluR1-IP3R1-calcium signaling	51
Functional connectivity of the amygdala subnuclei in various mood states of bipolar disorder	51
Relevance of interactions between dopamine and glutamate neurotransmission in schizophrenia	51
Disease-specific alterations in central fear network engagement during acquisition and extinction of conditioned interoceptive fear in inflammatory bowel disease	51
Rare variants implicate NMDA receptor signaling and cerebellar gene networks in risk for bipolar disorder	50
Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility	50
Influenza A virus during pregnancy disrupts maternal intestinal immunity and fetal cortical development in a dose- and time-dependent manner	49
Neurocognitive profiles of 22q11.2 and 16p11.2 deletions and duplications	49
Tractography-based versus anatomical landmark-based targeting in vALIC deep brain stimulation for refractory obsessive-compulsive disorder	49
Microglial type I interferon signaling mediates chronic stress-induced synapse loss and social behavior deficits	49
Cognitive deficits, clinical variables, and white matter microstructure in schizophrenia: a multisite harmonization study	49
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19	49
Shared genetic basis between reproductive behaviors and anxiety-related disorders	48
Dimensional Affective Sensitivity to Hormones across the Menstrual Cycle (DASH-MC): A transdiagnostic framework for ovarian steroid influences on psychopathology	48
Allosteric inhibition of NMDA receptors by low dose ketamine	48
Adherence to a psychobiotic diet stabilizes the microbiome and reduces perceived stress: plenty of food for thought	48
Multi-polygenic score prediction of mathematics, reading, and language abilities independent of general cognitive ability	48
Network state dynamics underpin basal craving in a transdiagnostic population	48
The universe is asymmetric, the mouse brain too	47
Complex functional phenotypes of NMDA receptor disease variants	47
Evidence for thyroid hormone regulation of amygdala-dependent fear-relevant memory and plasticity	47
MEK1/2 inhibition rescues neurodegeneration by TFEB-mediated activation of autophagic lysosomal function in a model of Alzheimer’s Disease	47
Medial prefrontal cortex Notch1 signalling mediates methamphetamine-induced psychosis via Hes1-dependent suppression of GABAB1 receptor expression	46
In vivo tractography of human locus coeruleus—relation to 7T resting state fMRI, psychological measures and single subject validity	46
Integration of valence and conflict processing through cellular-field interactions in human subgenual cingulate during emotional face processing in treatment-resistant depression	46
Global and local ancestry modulate APOE association with Alzheimer’s neuropathology and cognitive outcomes in an admixed sample	46
Correction: Stress-induced changes of the cholinergic circuitry promote retrieval-based generalization of aversive memories	46

The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder	46
Transcriptomic pathology of neocortical microcircuit cell types across psychiatric disorders	46
Correction to: Functional connectivity in reward circuitry and symptoms of anhedonia as therapeutic targets in depression with high inflammation: evidence from a dopamine challenge study	45
Digital phenotyping in molecular psychiatry—a missed opportunity?	45
Reply to “Comment on: What genes are differentially expressed in individuals with schizophrenia? A systematic review”	45
Behaviorally penetrant, anomalous dopamine efflux exposes sex and circuit dependent regulation of dopamine transporters	45
How to (not) decide about the motor vs psychomotor origin of psychomotor disturbances in depression	45
Respiratory disease in people with bipolar disorder: a systematic review and meta-analysis	45
A prediction model for electroconvulsive therapy effectiveness in patients with major depressive disorder from the Dutch ECT Consortium (DEC)	45
Targeting high-affinity nicotinic receptors protects against the functional consequences of β-amyloid in mouse hippocampus	45
A genetics-first approach to understanding autism and schizophrenia spectrum disorders: the 22q11.2 deletion syndrome	45
Prefrontal parvalbumin interneurons mediate CRHR1-dependent early-life stress-induced cognitive deficits in adolescent male mice	45
Development of opioid-induced hyperalgesia depends on reactive astrocytes controlled by Wnt5a signaling	45
Rare coding variants as risk modifiers of the 22q11.2 deletion implicate postnatal cortical development in syndromic schizophrenia	44
Cognitive functioning in people with psychotic experiences: a systematic review and meta-analysis study	44
Monoallelic loss-of-function variants in GSK3B lead to autism and developmental delay	44
Comment on “Perception of social inclusion/exclusion and response inhibition in adolescents with past suicide attempt: a multidomain task-based fMRI study.” by Gifuni et al.	44
Whole exome sequencing identified six novel genes for depressive symptoms	44
Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors	44
Correction: Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment	44
A causal association of ANKRD37 with human hippocampal volume	44
Causal and common risk pathways linking childhood maltreatment to later intimate partner violence victimization	44
Preventing incubation of drug craving to treat drug relapse: from bench to bedside	44
Are we getting closer to offering deep brain stimulation for treatment-resistant depression in clinical practice?	43
Intrinsically dysregulated cellular stress signaling genes and gene networks in postpartum depression	43
Developmental loss of ErbB4 in PV interneurons disrupts state-dependent cortical circuit dynamics	43
Integration of peripheral transcriptomics, genomics, and interactomics following trauma identifies causal genes for symptoms of post-traumatic stress and major depression	43
Age, sex, and apolipoprotein E isoform alter contextual fear learning, neuronal activation, and baseline DNA damage in the hippocampus	43
The need for a reliable oxytocin assay	42
Multi-ancestry genome-wide gene–sleep interactions identify novel loci for blood pressure	42
Neurite outgrowth deficits caused by rare PLXNB1 mutation in pediatric bipolar disorder	42
Genome-wide significant risk loci for mood disorders in the Old Order Amish founder population	42
State-specific alterations in the neural computations underlying inhibitory control in women remitted from bulimia nervosa	42
School achievement in adolescence and the risk of mental disorders in early adulthood: a Finnish nationwide register study	42
Hippocampal neurogenesis promotes preference for future rewards	41
The serotonin theory of depression	41
Quantitative magnetization transfer and g-ratio imaging of white matter myelin in early psychotic spectrum disorders	41
Medication effects on developmental sterol biosynthesis	41
GWAS-identified bipolar disorder risk allele in the FADS1/2 gene region links mood episodes and unsaturated fatty acid metabolism in mutant mice	41
Although serotonin is not a major player in depression, its precursor is	41
Resting mononuclear cell NR3C1 and SKA2 expression levels predict blunted cortisol reactivity to combat training stress among elite army cadets exposed to childhood adversity	41
Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury	40
Transcriptomic risk scores for attention deficit/hyperactivity disorder	40
LHPP, a risk factor for major depressive disorder, regulates stress-induced depression-like behaviors through its histidine phosphatase activity	40
Trans-ancestry epigenome-wide association meta-analysis of DNA methylation with lifetime cannabis use	40
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis	40
Cell type-specific manifestations of cortical thickness heterogeneity in schizophrenia	40
The Alzheimer’s disease risk gene BIN1 regulates activity-dependent gene expression in human-induced glutamatergic neurons	39
Transcriptome and chromatin alterations in social fear indicate association of MEG3 with successful extinction of fear	39
Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial	39
Resting-state EEG dynamic functional connectivity distinguishes non-psychotic major depression, psychotic major depression and schizophrenia	39
Rare copy number variation in posttraumatic stress disorder	39
Effects of sleep on the glymphatic functioning and multimodal human brain network affecting memory in older adults	39
Transcriptomic dysregulation and autistic-like behaviors in Kmt2c haploinsufficient mice rescued by an LSD1 inhibitor	39
Mechanisms of action of fluvoxamine for COVID-19: a historical review	39
The neurobiology of duration of untreated psychosis: a comprehensive review	38
Pharmacological and behavioral divergence of ketamine enantiomers: implications for abuse liability	38
Influences of dopaminergic system dysfunction on late-life depression	38
Re-examining the link between childhood maltreatment and substance use disorder: a prospective, genetically informative study	38
Functional connectivity signatures of major depressive disorder: machine learning analysis of two multicenter neuroimaging studies	38
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation	38
MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic intervention	38
Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease	37
Angiogenic gene networks are dysregulated in opioid use disorder: evidence from multi-omics and imaging of postmortem human brain	37
Activation of β2-adrenergic receptors prevents AD-type synaptotoxicity via epigenetic mechanisms	37
VEGF-A in serum protects against memory impairment in APP/PS1 transgenic mice by blocking neutrophil infiltration	37
Electroconvulsive therapy, electric field, neuroplasticity, and clinical outcomes	37
Amygdala DCX and blood Cdk14 are implicated as cross-species indicators of individual differences in fear, extinction, and resilience to trauma exposure	37
African ancestry GWAS of dementia in a large military cohort identifies significant risk loci	37
CPEB and translational control by cytoplasmic polyadenylation: impact on synaptic plasticity, learning, and memory	37
Hippocampal neurogenesis in adult primates: a systematic review	36
Using induced pluripotent stem cells to investigate human neuronal phenotypes in 1q21.1 deletion and duplication syndrome	36
CRHCeA→VTA inputs inhibit the positive ensembles to induce negative effect of opiate withdrawal	36
Cognitive performance protects against Alzheimer’s disease independently of educational attainment and intelligence	36
Prefrontal cortex astroglia modulate anhedonia-like behavior	36
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials	36
Mechanisms underlying capsulotomy for refractory obsessive-compulsive disorder: neural correlates of negative affect processing overlap with deep brain stimulation targets	36
Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-β-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning	36
The role of glial autophagy in Alzheimer’s disease	36
Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway	36
Internal capsule microstructure mediates the relationship between childhood maltreatment and PTSD following adulthood trauma exposure	36
Brain regions susceptible to alpha-synuclein spreading	36
Enhancing GluN2A-type NMDA receptors impairs long-term synaptic plasticity and learning and memory	35
Chronometric TMS-fMRI of personalized left dorsolateral prefrontal target reveals state-dependency of subgenual anterior cingulate cortex effects	35
A novel circular RNA, circIgfbp2, links neural plasticity and anxiety through targeting mitochondrial dysfunction and oxidative stress-induced synapse dysfunction after traumatic brain injury	35
Testing the causal relationships of physical activity and sedentary behaviour with mental health and substance use disorders: a Mendelian randomisation study	35
Sustained TNF signaling is required for the synaptic and anxiety-like behavioral response to acute stress	35
Top-down regulation of motivated behaviors via lateral septum sub-circuits	35
Neural mechanisms of emotional health in traumatic brain injury patients undergoing rTMS treatment	35
Theta burst stimulation for depression: a systematic review and network and pairwise meta-analysis	35
Targeting HINT1 to improve synaptic plasticity: toward loganin as a new antidepressant strategy	34
Whole-brain resting-state connectivity underlying impaired inhibitory control during early versus longer-term abstinence in cocaine addiction	34
Alzheimer’s disease biomarkers and their current use in clinical research and practice	34
Biogeography of the large intestinal mucosal and luminal microbiome in cynomolgus macaques with depressive-like behavior	34
Loss of liver X receptor β in astrocytes leads to anxiety-like behaviors via regulating synaptic transmission in the medial prefrontal cortex in mice	34